Sunil Gandhi, Ph.D.
Founding Chief Technology Officer at Savanna Bio
Irvine, California, United States
About Sunil Gandhi, Ph.D.
Sunil Gandhi, Ph.D. is Founding Chief Technology Officer at Savanna Bio. Location: Irvine, California, United States.
Dr. Gandhi has focused his scientific career on developing cell technology to tap the brain’s latent capacity to rewire itself. He received his graduate training with Charles Stevens, MD, PhD, at the Salk Institute where he studied the fundamental mechanisms of neurotransmitter release. As a postdoctoral fellow in Michael Stryker’s lab at UCSF, he made the exciting discovery that young interneurons implanted in older brains induced a rejuvenating period of brain plasticity. With the support of a New Innovator Award from the NIH Director, a Searle Scholars Award, and other prestigious grants, he has pioneered the use of embryonic inhibitory neuron transplantation to rewire the adult visual system. His lab discovered that transplanted inhibitory neurons successfully integrate into the circuitry of the adult host brain and correct developmental miswiring of the visual system in mice. More recently, the group has developed new methods for whole brain visualization using new brain clearing methods and light sheet microscopy. To disseminate these technologies to the neuroscience community, he has co-founded a BRAIN Initiative supported startup company Translucence Biosystems. The company successfully partnered with Zeiss Microscopy to develop and co-market a new microscopy system for higher resolution, faster light sheet microscopy of large, cleared samples.
Skills
Additional experience
Co-Founder
Translucence Biosystems
Started January 2018
Education
- Postdoctoral Fellow, University of California, San Francisco
- Ph.D., UC San Diego